Mode
Text Size
Log in / Sign up
N/A N=35 Randomized Supportive Care

Virtual Reality for Pain Management in Orthopaedic Patients

Pain, Musculoskeletal

Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcome: Primary: Opioid Usage During the Postoperative Hospitalization — 30.3; 30.8 Morphine milligram equivalents (MME)/day

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
VR device (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Nov 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Opioid Usage During the Postoperative Hospitalization
30.3; 30.8
SECONDARY
Length of Stay
2.5; 2
SECONDARY
Patient-reported Pain Scores
9.62; 9.0

Summary

1. Investigators will determine the feasibility of a virtual reality pain control program (VR-PCP) as a non-pharmacologic adjunct for pain management while in the hospital (i.e. patient ability and willingness to use the system measured by average time spent on the device). 2. Investigators will evaluate if there is a difference between the average daily use of opioid medications taken by patients who received usual care pain management versus patients using a VR-PCP. 3. Investigators will assess for differences in short-term postoperative patient-reported pain intensity (PROMIS Patient Intensity v1.0) for patients who received usual care pain management versus those who also have access to a VR-PCP.

Eligibility Criteria

Inclusion Criteria

  • 18 and older
  • Patients who sustained factures treated with open reduction internal fixation. Polytrauma patients whose fractures are definitively fixed in one discrete operating room visit will be included.

Exclusion Criteria

  • Cognitive impairment
  • Injuries requiring staged surgical fixation (i.e. ex-fix to ORIF)
  • Seizure disorder or other contraindication to VR usage
  • Significant medical complications during hospitalization precluding use of a VR headset
  • Significant surgical complication during hospitalization requiring unanticipated return to the operating room during index admission.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04152447). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search